Skip to content

Fused framework for predicting binding affinity to ɑ-synuclein using three-dimensional molecular graphs and attention.

Aug 2026 · Computational biology and chemistry · Vol 125, pp. 109292 · 0 citations · 50 references
Medicine

TL;DR

This work provides an accurate, robust, and interpretable computational tool for α‑syn inhibitor screening, and offers methodological insights into 3D structure‑based molecular representation learning for drug discovery.

Abstract

The aberrant aggregation of α‑synuclein (α‑syn) is a pathological hallmark of synucleinopathies, driving the need for small‑molecule inhibitors that block its oligomerization and fibrillization. In computer‑aided drug discovery, accurate affinity prediction remains critical for early‑stage screening. However, current deep learning models predominantly rely on 1D sequences or 2D topological graphs, failing to exploit stereochemical and geometric cues from 3D space. Moreover, dedicated high‑precision predictors for intrinsically disordered targets such as α‑syn are scarce. To bridge this gap, we compiled a dataset of 9628 α‑syn‑binding compounds from ChEMBL and developed a deep learning framework that integrates Graph Attention Networks (GAT) with Graph Convolutional Networks (GCN). The core innovation lies in using 3D Euclidean interatomic distances as edge features to capture spatial interaction patterns within molecular conformations. We further incorporated an atomic attention layer and a composite loss function combining mean squared error (MSE) with Pearson correlation. The final model achieved an average MSE of 0.1751 and a Pearson correlation of 0.5703 over 10 independent runs, surpassing all baseline GNNs and a recently published α‑syn‑specific predictor. Bootstrap‑calibrated confidence intervals confirmed robustness against noise and conformational perturbations. Under a stringent cluster‑exclusion split, GAT‑GCN exhibited performance degradation comparable to other architectures while retaining the best overall metrics, demonstrating generalization to novel chemical scaffolds. This work provides an accurate, robust, and interpretable computational tool for α‑syn inhibitor screening, and offers methodological insights into 3D structure‑based molecular representation learning for drug discovery.

View source

Similar papers

Sep 2026

LGBind: A structure-guided deep learning framework for accurate prediction of protein-ligand binding sites.

LGBind is introduced, a structure-guided deep learning framework for generalized, ligand-conditioned binding site identification and demonstrates profound robustness and generalization in predicting novel ligand-target interactions, and demonstrates remarkable versatility.

Yun-Feng Li, Xing-Yu Liu, Yi-Jia Liu et al. · 0 citations
Open access Jan 2026

An algebraic graph neural network model for protein-ligand binding affinity prediction

An Algebraic Graph Neural Network model designed to encode molecular structures into a low-dimensional graph representation while preserving critical biochemical interactions is introduced, demonstrating superior performance in binding affinity prediction compared to state-of-the-art scoring functions.

Augustine Ouru, Xi Chen, Cameron Yeagle et al. · 0 citations
Sep 2026

Accelerating HDAC8 inhibitor discovery through deep learning, cheminformatics, docking, and molecular dynamics simulations.

Histone deacetylase 8 (HDAC8) is an emerging epigenetic target implicated in cancer, neurodegenerative disorders, and other human diseases, driving the urgent need for potent and selective inhibitors. In this study, we developed and validated a deep learning-based computational pipeline for the accurate prediction of H...

M. Sargolzaei, H. Nikoofard · 0 citations
Aug 2026

Predicting circRNA-Drug Sensitivity Using Integrated Hybrid Graph and Molecular Features.

Case studies further validated predicted circRNA-drug associations, including cisplatin, enzalutamide, and sorafenib, against published experimental findings, demonstrating HMCDSP's capacity to reveal clinically relevant biomarkers and inform personalized therapeutic strategies.

Yong-Tian Wang, Wen-Kai Shen, Jiahao Li et al. · 1 citation
Open access Aug 2026

Graph Neural Network Model for Predicting Mitochondrial Toxicity via Complementary Molecular Features

A hybrid Graph Neural Network model for predicting mitochondrial toxicity, a significant contributor to drug-induced liver injury, which effectively captures both the structural and physicochemical properties of compounds by integrating graph embeddings and molecular fingerprints is introduced.

Phat Dat Nguyen, Trong Phuc Le, Dinh Khanh Ngan Nguyen et al. · 0 citations
Open access Oct 2026

A Hybrid Ligand- and Structure-Based Drug Design Invoked through Square Attention in Protein–Ligand Transformer

Computer-aided molecular design based on evaluation of protein–ligand (PL) binding affinity is important for accelerating drug discovery. A deep-learning model for natural language processing (NLP) involving an attention mechanism (i.e., Transformer) is expected to improve the PL-affinity evaluation along with clarif...

Yan-Hui Lu, Yasunori Ohara, Hayato Kunugi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.